Literature DB >> 33358588

A pilot study for presence of circulating tumour cells in adenoid cystic carcinoma.

B M Fisher1, K D Tang2, M E Warkiani3, C Punyadeera4, M D Batstone5.   

Abstract

Adenoid cystic carcinoma (ACC) is a rare salivary gland neoplasm with a poor long-term prognosis due to multiple recurrences and distant metastatic spread. Circulating tumour cells (CTCs) are tumour cells shed from a primary, recurrent, or metastatic cancer that are detectable in the blood or lymphatics. There is no literature to date confirming the presence of CTCs in ACC. The aim of this study was to determine whether CTCs are detectable in ACC. Blood samples were collected from eight patients with histologically confirmed ACC. The TNM stage of the tumour was recorded, as well as any prior treatment. CTCs were isolated by spiral microfluidics and detected by immunofluorescence staining. Three of the eight patients recruited (32.5%) had staining consistent with the presence of CTCs. Of these three patients with detectable CTCs, one had confirmed pulmonary metastasis, one had suspected pulmonary metastasis and was awaiting confirmation, and one had local recurrence confirmed on re-resection. One patient with known isolated pulmonary metastasis had previously undergone a lung metastasectomy and did not have CTCs detected. CTCs are detectable in ACC. In this small patient sample, CTCs were found to be present in those patients with recurrent local disease and known distant metastatic disease. CTCs in ACC should be investigated further for their potential use as an adjunct in staging, prognosis, and the detection of recurrence.
Copyright © 2020 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenoid cystic; Carcinoma; Circulating; Flourescent antibody technique; Microfluidics; Neoplasm recurrence; Neoplastic cells; Salivary gland neoplasms

Year:  2020        PMID: 33358588     DOI: 10.1016/j.ijom.2020.11.012

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  3 in total

Review 1.  Liquid Biopsy in Head and Neck Cancer: Current Evidence and Future Perspective on Squamous Cell, Salivary Gland, Paranasal Sinus and Nasopharyngeal Cancers.

Authors:  Santiago Cabezas-Camarero; Pedro Pérez-Segura
Journal:  Cancers (Basel)       Date:  2022-06-09       Impact factor: 6.575

2.  Application of circulating tumour cells to predict response to treatment in head and neck cancer.

Authors:  Xi Zhang; Chameera Ekanayake Weeramange; Brett G M Hughes; Sarju Vasani; Zhen Yu Liu; Majid Ebrahimi Warkiani; Gunter Hartel; Rahul Ladwa; Jean Paul Thiery; Liz Kenny; Chamindie Punyadeera
Journal:  Cell Oncol (Dordr)       Date:  2022-06-23       Impact factor: 7.051

3.  Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer.

Authors:  Joanna Kapeleris; Juliana Müller Bark; Shanon Ranjit; Darryl Irwin; Gunter Hartel; Majid Ebrahimi Warkiani; Paul Leo; Connor O'Leary; Rahul Ladwa; Kenneth O'Byrne; Brett G M Hughes; Chamindie Punyadeera
Journal:  Heliyon       Date:  2022-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.